Latest Market Research Reports

  Preimplantation Genetic Testing Industry The global preimplantation genetic testing market size was estimated at USD 802.2 million in 2023 and is expected to grow at a CAGR of 10.3% from 2024 to 2030. The growing prevalence of single gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming years. The Florida Department of Health reports that approximately one in every 33 babies in the U.S. is born with a congenital disability, impacting nearly 120,000 babies each year. With new tests being launched, the demand is expected to grow in coming years. For instance, in July 2023, Thermo Fisher Scientific Inc. launched 2 tests based on NGS for preimplantation genetic testing-aneuploidy (PGT-A). Preimplantation genetic diagnosis (PGD) is utilized prior to the IVF process to ensure a successful pregnancy. PGD is employed in IVF cycles for women who have experienced multiple miscarriages or previous...

  Preimplantation Genetic Testing Industry The global  preimplantation genetic testing market  size is expected to reach USD 1.54 billion by 2030, growing at 10.3% CAGR from 2024 to 2030, as per the new report by Grand View Research, Inc. Recent technological advancements in testing have changed the current practice of prenatal screening and early detection of chromosomal abnormalities in an embryo. Moreover, the introduction of novel technologies such as NGS, PCR, and FISH is expected to drive market growth over the forecast period. Growing awareness about genetic diseases and novel techniques for the detection of chromosomal abnormalities and embryo screening for successful IVF holds growth prospects for this vertical over the forecast period. Key market players and service providers such as COOPER SURGICAL, INC. are running awareness campaigns to promote an increased understanding of the diseases and screening of these diseases at the early stages. Such ...

  Preimplantation Genetic Testing Industry Overview The global preimplantation genetic testing market size was estimated at USD 802.2 million in 2023 and is expected to grow at a CAGR of 10.3% from 2024 to 2030. The growing prevalence of single gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming years. The Florida Department of Health reports that approximately one in every 33 babies in the U.S. is born with a congenital disability, impacting nearly 120,000 babies each year. With new tests being launched, the demand is expected to grow in coming years. For instance, in July 2023, Thermo Fisher Scientific Inc. launched 2 tests based on NGS for preimplantation genetic testing-aneuploidy (PGT-A). Gather more insights about the market drivers, restrains and growth of the  Preimplantation Genetic Testing Market Preimplantation genetic diagnosis (PGD) is utilized prior to the IVF process...